63
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Extended haplotype association study in Crohn’s disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-κB pathway gene, HEATR3

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The Ashkenazi Jewish population has a several-fold higher prevalence of Crohn’s disease compared to non-Jewish European ancestry populations and has a unique genetic history. Haplotype association is critical to Crohn’s disease etiology in this population, most notably at NOD2, in which three causal, uncommon, and conditionally independent NOD2 variants reside on a shared background haplotype. We present an analysis of extended haplotypes which showed significantly greater association to Crohn’s disease in the Ashkenazi Jewish population compared to a non-Jewish population (145 haplotypes and no haplotypes with P-value < 10 −3, respectively). Two haplotype regions, one each on chromosomes 16 and 21, conferred increased disease risk within established Crohn’s disease loci. We performed exome sequencing of 55 Ashkenazi Jewish individuals and follow-up genotyping focused on variants in these two regions. We observed Ashkenazi Jewish-specific nominal association at R755C in TRPM2 on chromosome 21. Within the chromosome 16 region, R642S of HEATR3 and rs9922362 of BRD7 showed genome-wide significance. Expression studies of HEATR3 demonstrated a positive role in NOD2-mediated NF-κB signaling. The BRD7 signal showed conditional dependence with only the downstream rare Crohn’s disease-causal variants in NOD2, but not with the background haplotype; this elaborates NOD2 as a key illustration of synthetic association.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

          Crohn's disease and ulcerative colitis, the two main types of chronic inflammatory bowel disease, are multifactorial conditions of unknown aetiology. A susceptibility locus for Crohn's disease has been mapped to chromosome 16. Here we have used a positional-cloning strategy, based on linkage analysis followed by linkage disequilibrium mapping, to identify three independent associations for Crohn's disease: a frameshift variant and two missense variants of NOD2, encoding a member of the Apaf-1/Ced-4 superfamily of apoptosis regulators that is expressed in monocytes. These NOD2 variants alter the structure of either the leucine-rich repeat domain of the protein or the adjacent region. NOD2 activates nuclear factor NF-kB; this activating function is regulated by the carboxy-terminal leucine-rich repeat domain, which has an inhibitory role and also acts as an intracellular receptor for components of microbial pathogens. These observations suggest that the NOD2 gene product confers susceptibility to Crohn's disease by altering the recognition of these components and/or by over-activating NF-kB in monocytes, thus documenting a molecular model for the pathogenic mechanism of Crohn's disease that can now be further investigated.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Inflammatory bowel disease.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

              Nod2 activates the NF-kappaB pathway following intracellular stimulation by bacterial products. Recently, mutations in Nod2 have been shown to be associated with Crohn's disease, suggesting a role for bacteria-host interactions in the etiology of this disorder. We show here that Nod2 is a general sensor of peptidoglycan through the recognition of muramyl dipeptide (MDP), the minimal bioactive peptidoglycan motif common to all bacteria. Moreover, the 3020insC frameshift mutation, the most frequent Nod2 variant associated with Crohn's disease patients, fully abrogates Nod2-dependent detection of peptidoglycan and MDP. Together, these results impact on the understanding of Crohn's disease development. Additionally, the characterization of Nod2 as the first pathogen-recognition molecule that detects MDP will help to unravel the well known biological activities of this immunomodulatory compound.
                Bookmark

                Author and article information

                Journal
                100953417
                21482
                Genes Immun
                Genes Immun.
                Genes and immunity
                1466-4879
                1476-5470
                6 September 2013
                25 April 2013
                Jul-Aug 2013
                01 January 2014
                : 14
                : 5
                : 310-316
                Affiliations
                [1 ]Department of Medicine, Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT, USA
                [2 ]Department of Epidemiology, Harvard University, Boston, MA, USA
                [3 ]Department of Pathology, University of Michigan School of Medicine, Ann Arbor, MI, USA
                [4 ]Department of Genetics, Yale University School of Medicine, New Haven, CT, USA
                [5 ]Department of Genetics & Genomic Sciences, Mount Sinai School of Medicine, New York, NY, USA
                [6 ]Center for Applied Genomics, The Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
                [7 ]Department of Gastroenterology, Rambam Health Care Campus, B. Rappaport, Institute for Research in the Medicine Science, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
                [8 ]Meyerhoff Inflammatory Bowel Disease Center, Department of Medicine, Johns Hopkins University School of Medicine, Department of Epidemiology, Johns Hopkins University 8Bloomberg School of Public Health, Baltimore, MD, USA
                [9 ]IBD Group, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada
                [10 ]Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, North Shore LIJ Health System, Manhasset, NY, USA
                [11 ]North Shore University Hospital-Long Island, Jewish Hospital Systems, St. Francis Hospital, Great Neck, NY, USA
                [12 ]Department of Epidemiology and Public Health, Yale School of Medicine, New Haven, CT, USA
                [13 ]Department of Computer Science, Columbia University, New York, NY, USA
                Author notes
                [* ]Corresponding author, Judy H. Cho, Departments of Medicine and Genetics, Yale University School of Medicine, Phone: 203-785-5610, Fax: 203-785-5673, judy.cho@ 123456yale.edu
                [#]

                These authors contributed equally to this work.

                Article
                NIHMS458938
                10.1038/gene.2013.19
                3785105
                23615072
                f507c57a-7905-45b6-bb86-dc99b08eb62d

                Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Funding
                Funded by: National Institute of Diabetes and Digestive and Kidney Diseases : NIDDK
                Award ID: U01 DK062429 || DK
                Funded by: National Institute of Diabetes and Digestive and Kidney Diseases : NIDDK
                Award ID: U01 DK062422 || DK
                Funded by: National Institute of General Medical Sciences : NIGMS
                Award ID: T32 GM007205 || GM
                Funded by: National Institute of Diabetes and Digestive and Kidney Diseases : NIDDK
                Award ID: R01 DK092235 || DK
                Funded by: National Institute of Diabetes and Digestive and Kidney Diseases : NIDDK
                Award ID: P01 DK072201 || DK
                Categories
                Article

                Genetics
                haplotype association,ashkenazi jewish,crohn’s disease,nf-κb signaling,synthetic association

                Comments

                Comment on this article